Metformin Pancreatic Cancer Risk: What You Need to Know
In the wake of new findings that Metformin is contaminated with cancer-causing NDMA, many are asking, “Does Metformin cause pancreatic cancer?” In this article, we’ll share what is known about potential Metformin pancreatic cancer risk, and how those affected can file a Metformin cancer claim.
IMPORTANT: If you’ve been diagnosed with pancreatic cancer (or another type of cancer) after taking the diabetes medication Metformin, you may be entitled to compensation. For a FREE, no-obligation consultation with a Metformin cancer lawyer, please call 1-800-525-7111 or complete the fast and easy form below. There are no attorney fees unless we win your case and you receive compensation.
Metformin and NDMA Contamination
In late 2019, an independent lab named Valisure discovered levels of NDMA (N-Nitrosodimethylamine) in Metformin. NDMA is a dangerous, naturally occurring chemical that is known to cause cancer. The Environmental Protection Agency (EPA), the World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC) all consider NDMA as “probable carcinogenic.”
This means that NDMA may cause cancer in humans, including pancreatic cancer.
In response to these findings, the Food and Drug Administration (FDA) issued a warning about Metformin and potential cancer risk and launched its own investigation. Voluntary Metformin recalls followed.
Metformin and Pancreatic Cancer: What’s the Risk?
To be clear, no research has drawn a definitive link between Metformin and pancreatic cancer, however, based on known NDMA contamination, potential Metformin pancreatic cancer risk is likely.
Recent scientific evidence shows a clear link between NDMA (the dangerous chemical found in Metformin) and cancers of the digestive tract, including pancreatic cancer.
NDMA and Pancreatic Cancer
A 2003 study found that “Many features of the evidence … of pancreatic cancer appear to support connections with N-nitroso compounds [including NDMA].”
While a later study in 2019 did not find definitive evidence that NDMA causes pancreatic cancer, it did conclude that “biologically plausible finding for pancreatic carcinogens, NDEA and NDMA, warrant further prospective investigation.”
In a related dangerous drug case, many plaintiffs have filed lawsuits against Zantac alleging that NDMA in the popular heartburn medication causes pancreatic cancer. Our firm is actively investigating these claims, as well.
Have you been diagnosed with pancreatic cancer (or another type of cancer) after taking Metformin? You may be entitled to compensation — call 1-800-525-7111 today for a FREE, no-obligation consultation with an experienced Metformin cancer lawyer.
There are no upfront costs and no attorney fees unless we recover compensation for you.
Call 1-800-525-7111 and let’s investigate your Metformin pancreatic cancer claim.
Other cancers potentially linked to NDMA in Metformin include:
- Esophageal cancer
- Throat / nasal cancer
- Stomach cancer
- Bladder cancer
- Kidney cancer
- Liver cancer
- Intestinal cancer
- Thyroid cancer
- Brain cancer
- Pancreatic cancer
- Prostate cancer
- Testicular cancer
- Ovarian cancer
- Breast cancer
- Lung cancer
- Non-Hodgkins lymphoma
- Multiple myeloma
Experienced Injury Lawyers Handling Metformin Cancer Claims
Since 1985, our injury lawyers have been handling dangerous drug claims and helping hold potentially negligent drug manufacturers accountable. We have recovered millions of dollars in compensation for our deserving clients (see disclaimer below), and we’re proud of the words our clients use to describe their experience working with our firm:
- “It was nice to see Riddle & Brantley put me and my needs first.” – Colley
- “I would recommend them to anyone. They fought hard for me.” –Christine W.
- “They handled my case very professionally, with respect from beginning to end.” –Joseph P.
- “They made a hard time in my life easier to endure.” –Melissa C.
- “Every time I’ve needed them, they were there for me.” -Tyronnie T.
“I would not have won my case without the help from my team at Riddle & Brantley.”
–John S., Riddle & Brantley client
Our experienced Metformin cancer lawyers are led by Gene Riddle, an attorney who has been honored with membership in such prestigious organizations as Multi-Million Dollar Advocates Forum, Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, and The National Association of Distinguished Counsel. He is also the recipient of the 2014 Litigator Award and maintains a top-tier AV Preeminent rating from Martindale-Hubbell (see disclaimer below).
If you’ve suffered from pancreatic cancer or another type of cancer after taking Metformin, you may be eligible for a Metformin lawsuit or cancer claim and we would love to help you get justice if we can.
Please call 1-800-525-7111 today and let an experienced Metformin cancer attorney review your case and advise you on your legal options.
Justice Counts for those who have suffered from cancer as a result of dangerous drugs, and if Metformin caused your pancreatic cancer (or other type of cancer), we want to help.
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.
*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, The National Association of Distinguished Counsel, AV Preeminent by Martindale-Hubbell, the Litigator Award, and other memberships, awards, and accolades, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.